Dr. Manuel Comabella MD, PhD Neurologist. Neurology / Neuroimmunology Department. Vall d’Hebron University Hospital Director of Laboratory. MS Centre of Catalonia Vall d’Hebron University Hospital Barcelona | Spain
Dr. Manuel Comabella earned his medical degree at the University of Barcelona, completed his neurology residency at the Neurology Department of the Hospital Universitari Vall d’Hebron (HUVH), and earned his PhD at the Universitat Autònoma de Barcelona. From 1996 to 1998 he was a Research Fellow in Neuroimmunology at the Center for Neurologic Diseases, Brigham and Women´s Hospital, in Boston. In 2010 was awarded with the Ayudas Merck Serono in the multiple sclerosis research area. In 2011 was awarded by the Spanish Society of Neurology (SEN) with the Biogen Idec Prize to the best publication on demyelinating disorders. In 2013 was awarded by the SEN with the Novartis Prize to the best oral communication and the best publication on demyelinating disorders. In 2014 received the Neurological Disorders Award, scientific modality, granted by the SEN. In 2016 was awarded with the Ayudas Merck Serono in the multiple sclerosis research area.
Since 2004, Dr. Manuel Comabella is the Head of the Clinical Neuroimmunology laboratory at the Fundació Institut de Recerca del HUVH. Since 2013 he is Coordinator of Neurosciences and member of the Internal Scientific Committee at the Fundació Institut de Recerca del HUVH. Since July 2018 he is collaborator of the Biomedicine area at the Division of Coordination, Evaluation and Scientific and Technical Follow-up of the State Research Agency, Ministry of Science, Innovation and Universities. Since June 2008 he works as a clinical neurologist at the Department of Neurology / Neuroimmunology of the MS Centre of Catalonia (Cemcat), HUVH, Barcelona.
Dr. Manuel Comabella is member of the Editorial Board of Journal of Neuroimmunology and Multiple Sclerosis Journal, member of the Board of the ESNI (European School of Neuroimmunology), member of the Strategic Group of the IMSGC (International Multiple Sclerosis Genetics Consortium), and Coordinator of the BioMSeu (European Consortium for CSF Biomarker Research). He is coauthor of 253 documents indexed in MedLine (Scopus: 9363 total citations, with h-index of 46). Dr. Manuel Comabella’s research interest lies in the identification of biomarkers related with different aspects of multiple sclerosis and the development of new therapeutic strategies for the disease.